603259 药明康德
已收盘 08-20 15:00:00
资讯
新帖
简况
药明康德（603259）披露2026年半年度业绩说明会召开安排，8月20日股价上涨2.38%
证券之星 · 08-20 22:00
药明康德（603259）披露2026年半年度业绩说明会召开安排，8月20日股价上涨2.38%
瑞银集团在药明康德H股的空头仓位8月12日由3.22%降至2.71%——港交所披露
美股速递 · 08-18 18:24
瑞银集团在药明康德H股的空头仓位8月12日由3.22%降至2.71%——港交所披露
瑞银集团在药明康德的H股好仓比例上升0.72%至7.67%
南方财经网 · 08-18 17:18
瑞银集团在药明康德的H股好仓比例上升0.72%至7.67%
法国巴黎银行在药明康德的H股好仓比例上升0.51%至5.37%
南方财经网 · 08-18 17:17
法国巴黎银行在药明康德的H股好仓比例上升0.51%至5.37%
贝莱德增持药明康德(02359)约33.76万股 每股作价约198.87港元
智通财经 · 08-17
贝莱德增持药明康德(02359)约33.76万股 每股作价约198.87港元
港股收评：恒指、恒科齐大涨；半导体全天爆发；硬件设备、有色、汽车、银行上涨；造纸、食品饮料下跌；科网股普涨；药明康德创新高
中新经纬 · 08-17
港股收评：恒指、恒科齐大涨；半导体全天爆发；硬件设备、有色、汽车、银行上涨；造纸、食品饮料下跌；科网股普涨；药明康德创新高
CXO再度爆发，药明康德H股叒新高！华宝基金港股通医疗ETF（159137）上探3.5%，标的指数CXO含量全市场第一
新浪基金 · 08-17
CXO再度爆发，药明康德H股叒新高！华宝基金港股通医疗ETF（159137）上探3.5%，标的指数CXO含量全市场第一
药明康德A、H股双双涨超4%创历史新高 总市值突破5000亿
每日经济新闻 · 08-17
药明康德A、H股双双涨超4%创历史新高 总市值突破5000亿
【特约大V】邓声兴：港股走势反复，恒指考验100天线
金吾财讯 · 08-17
【特约大V】邓声兴：港股走势反复，恒指考验100天线
摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据
美股速递 · 08-14
摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据
CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳
新浪基金 · 08-13
CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳
美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价
智通财经 · 08-13
美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价
大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价
格隆汇 · 08-13
大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价
药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
金吾财讯 · 08-11
药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选
药明康德：公司将于2026年9月29日召开2026年第一次临时股东会
证券日报网 · 08-10
药明康德：公司将于2026年9月29日召开2026年第一次临时股东会
大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素
格隆汇 · 08-10
大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素
研报掘金丨国盛证券：维持药明康德“买入”评级，大幅上调全年指引
格隆汇 · 08-10
研报掘金丨国盛证券：维持药明康德“买入”评级，大幅上调全年指引
时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！
新浪基金 · 08-10
时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！
AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令
格隆汇 · 08-10
AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令
撕掉重资产标签，药明康德（02359）利润为何越跑越快？
智通财经 · 08-10
撕掉重资产标签，药明康德（02359）利润为何越跑越快？
加载更多
公司概况
公司名称：
无锡药明康德新药开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2018-05-08
主营业务：
无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。
发行价格：
21.60
{"stockData":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":167.9,"timestamp":1787209200000,"preClose":164,"halted":0,"volume":85911366,"delay":0,"changeRate":0.0238,"floatShares":2473000000,"shares":2984000000,"eps":7.2627,"marketStatus":"已收盘","change":3.9,"latestTime":"08-20 15:00:00","open":171,"high":173.6,"low":165.97,"amount":14588999999.999998,"amplitude":0.0465,"askPrice":167.9,"askSize":1356,"bidPrice":167.89,"bidSize":15,"shortable":0,"etf":0,"ttmEps":7.2627,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787275800000},"marketStatusCode":5,"adr":0,"adjPreClose":164,"symbolType":"stock","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":180.4,"lowLimit":147.6,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2983757155,"isCdr":false,"pbRate":6.01,"roa":"--","peRate":23.118124,"roe":"13.19%","epsLYR":6.7,"committee":-0.713122,"marketValue":500972999999.9999,"turnoverRate":0.0347,"status":0,"hkstockBrief":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":206.6,"timestamp":1787213349008,"preClose":202,"halted":0,"volume":10146478,"delay":0,"premium":"+5.49"},"floatMarketCap":415264000000.0001},"requestUrl":"/m/hq/s/603259","defaultTab":"news","newsList":[{"id":"2660280152","title":"药明康德（603259）披露2026年半年度业绩说明会召开安排，8月20日股价上涨2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660280152","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660280152?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:00","pubTimestamp":1787234453,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，药明康德报收于167.9元，较前一交易日上涨2.38%，最新总市值为5009.73亿元。近日，药明康德发布《关于召开2026年半年度业绩说明会的公告》。公告显示，公司将于2026年8月28日上午9:00-10:00通过上证路演中心召开2026年半年度业绩说明会，以视频直播和网络互动形式进行。投资者可于2026年8月21日至8月27日16:00前通过上证路演中心提问预征集栏目或发送邮件至ir@wuxiapptec.com提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000044548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","LU0320764599.SGD","LU2495084118.USD","LU0348766576.USD","LU2328871848.SGD","IE00BPRC5H50.USD","LU0348767384.USD","LU1934453819.USD","LU2242644610.SGD","LU1997245177.USD","BK1583","LU2045819591.USD","LU2488822045.USD","LU1770034418.SGD","LU0456842615.SGD","LU1997244956.HKD","LU0700851271.USD","BK0216","02359","LU2125910500.SGD","LU0052750758.USD","LU1969619763.USD","LU0572944931.SGD","LU0327786744.USD","LU1979443071.USD","BK1576","LU1997245094.SGD","LU0611395673.USD","LU0708995583.HKD","LU1046422090.SGD","IE00B5MMRT66.SGD","LU1808992512.USD","LU0469268626.HKD","LU1251922891.USD","IE00B543WZ88.USD","LU1303224171.USD","603259","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156895845","title":"瑞银集团在药明康德H股的空头仓位8月12日由3.22%降至2.71%——港交所披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1156895845","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156895845?lang=zh_cn&edition=full","pubTime":"2026-08-18 18:24","pubTimestamp":1787048650,"startTime":"0","endTime":"0","summary":"据香港交易所最新披露的数据，瑞银集团在药明康德H股上的空头仓位已从8月12日的3.22%显著下调至2.71%。这一变化反映出该机构近期对这家中国医药研发服务巨头持仓策略的调整。值得注意的是，这一仓位变动幅度为0.51个百分点，在当前的港股市场中颇为引人关注。药明康德作为全球领先的药物研发及生产服务供应商，其一举一动都牵动着投资者的神经。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","LU2488822045.USD","BK1583","LU0572944931.SGD","LU1808992512.USD","LU0052750758.USD","LU1046422090.SGD","LU1997244956.HKD","LU1934453819.USD","LU0708995583.HKD","LU2495084118.USD","LU1770034418.SGD","LU0320764599.SGD","LU1997245177.USD","LU2125910500.SGD","LU0456842615.SGD","IE00B543WZ88.USD","LU2328871848.SGD","BK1576","LU1969619763.USD","IE00BPRC5H50.USD","LU0700851271.USD","LU0469268626.HKD","BK0216","LU1719994722.HKD","LU1303224171.USD","LU0611395673.USD","LU1979443071.USD","BK1141","02359","IE00B5MMRT66.SGD","LU0348766576.USD","LU1997245094.SGD","LU2242644610.SGD","LU0348767384.USD","LU0327786744.USD","LU1251922891.USD","LU2045819591.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660125465","title":"瑞银集团在药明康德的H股好仓比例上升0.72%至7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660125465","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660125465?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:18","pubTimestamp":1787044680,"startTime":"0","endTime":"0","summary":"南财智讯8月18日电，香港交易所披露信息显示，UBSGroupAG（瑞银集团）在药明康德的H股好仓（L）比例于8月11日从6.95%上升至7.67%。同时淡仓（S）比例从2.84%升至3.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608183844624828.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608183844624828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02359","LU1969619763.USD","IE00B543WZ88.USD","LU1303224171.USD","LU0320764599.SGD","LU1719994722.HKD","BK1141","603259","LU0611395673.USD","LU1251922891.USD","BK0216","LU0469268626.HKD","LU1934453819.USD","LU0456842615.SGD","LU0708995583.HKD","LU2495084118.USD","BK1576","LU1997245177.USD","LU1997245094.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1583","LU0052750758.USD","LU0348767384.USD","LU2328871848.SGD","LU0327786744.USD","LU0700851271.USD","LU1808992512.USD","LU0572944931.SGD","LU1046422090.SGD","LU2045819591.USD","LU0348766576.USD","LU2125910500.SGD","LU1979443071.USD","LU1997244956.HKD","LU2242644610.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660651694","title":"法国巴黎银行在药明康德的H股好仓比例上升0.51%至5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660651694","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660651694?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:17","pubTimestamp":1787044620,"startTime":"0","endTime":"0","summary":"南财智讯8月18日电，香港交易所披露信息显示，BNPPARIBASSA（法国巴黎银行）在药明康德的H股好仓（L）比例于8月13日从4.86%上升至5.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608183844625054.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608183844625054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2495084118.USD","LU0327786744.USD","LU1251922891.USD","LU2125910500.SGD","603259","BK1576","LU0348766576.USD","LU0320764599.SGD","LU2488822045.USD","LU0348767384.USD","LU1997245094.SGD","LU1303224171.USD","IE00BPRC5H50.USD","LU1808992512.USD","LU0456842615.SGD","LU1997245177.USD","LU2045819591.USD","02359","LU1046422090.SGD","LU1979443071.USD","LU0700851271.USD","LU0572944931.SGD","LU0708995583.HKD","LU1719994722.HKD","LU0611395673.USD","LU1997244956.HKD","LU1770034418.SGD","LU2328871848.SGD","IE00B543WZ88.USD","LU1934453819.USD","LU0469268626.HKD","BK0216","LU0052750758.USD","LU1969619763.USD","IE00B5MMRT66.SGD","LU2242644610.SGD","BK1583","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484411","title":"贝莱德增持药明康德(02359)约33.76万股 每股作价约198.87港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484411","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660484411?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:06","pubTimestamp":1786964798,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，8月12日，贝莱德增持药明康德(02359)33.7637万股，每股作价198.8658港元，总金额约为6714.45万港元。增持后最新持股数目约为3064.08万股，最新持股比例为6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BGHQF748.EUR","LU1770034418.SGD","LU0731783048.USD","LU2592432038.USD","LU2125910500.SGD","LU1670627923.USD","LU1808992512.USD","LU2430703095.HKD","BK4534","LU0640476718.USD","LU1201861249.SGD","IE00B5MMRT66.SGD","LU1481011911.USD","LU2045819591.USD","BK4535","LU0130102774.USD","LU0742537680.HKD","LU0208291251.USD","LU0320764599.SGD","LU1997244956.HKD","LU0572944931.SGD","LU1481011671.HKD","LU2430703178.SGD","IE00B3QW5Z07.USD","LU1064131342.USD","BK4504","LU1988902786.USD","LU2264538146.SGD","LU1509826696.USD","LU0648001328.SGD","LU1366333091.USD","LU2488822045.USD","FDFF","BK4585","LU1997245177.USD","BLK","IE00BDGV0183.EUR","EWH","BK4581","LU2242644610.SGD","BK1576","BK1141","LU1934453819.USD","IE00BVYPNV92.GBP","BK4135","02359","LU1979443071.USD","BK0216","603259","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660839664","title":"港股收评：恒指、恒科齐大涨；半导体全天爆发；硬件设备、有色、汽车、银行上涨；造纸、食品饮料下跌；科网股普涨；药明康德创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2660839664","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660839664?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:15","pubTimestamp":1786954500,"startTime":"0","endTime":"0","summary":"17日，港股主要指数全天高开高走，恒生科技指数盘中涨超2%。截至收盘，恒指涨1.34%，恒生科技指数涨1.58%。盘面上，半导体板块全天领涨，天数智芯、澜起科技、兆易创新、华虹宏力、中芯国际等涨幅居前。硬件设备、有色金属、汽车、非银金融、机械、化工、银行等多数板块纷纷上涨。造纸、食品饮料等板块下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202608173843177648.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202608173843177648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09115","UGE","HHImain","SOXL","CHPS","XLPX","07300","CHPY","KXI","VGT","07500","03423","159843","159876","TEKX","PSI","SMH","603259","HSI","02359","MCHmain","SOXS","83115","SOXX","NBDS","XSD","MHImain","02833","02800","513600","161121","FWD","MQQQ","TECY","USD","159582","TRUO","CWC","VXUS","SOXY","KCAI","07226","EIS","SSG","IYK","SOXQ","SMHX","000807.SH","FTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660138101","title":"CXO再度爆发，药明康德H股叒新高！华宝基金港股通医疗ETF（159137）上探3.5%，标的指数CXO含量全市场第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2660138101","media":"新浪基金","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660138101?lang=zh_cn&edition=full","pubTime":"2026-08-17 11:19","pubTimestamp":1786936740,"startTime":"0","endTime":"0","summary":"8月17日，港股通医疗板块强势反弹，CXO再度领涨，药明康德港股再创历史新高！场内热门ETF方面，可T+0交易的港股通医疗ETF华宝盘中上探3.5%收复5日线！数据显示，其标的指数CXO含量达52.5%，在全市场可投资指数中为最高，其中药明系权重占比超38%，同样高居首位。最新CXO含量达32.82%，其中药明康德（A股）占比13.42%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-17/doc-ininqtns0348637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0611395673.USD","LU1808992512.USD","FLHK","LU0327786744.USD","LU1719994722.HKD","BK1583","LU2488822045.USD","02359","LU1303224171.USD","159137","LU0469268626.HKD","LU1934453819.USD","LU0708995583.HKD","WX","LU1046422090.SGD","LU2328871848.SGD","IE00BPRC5H50.USD","603259","BK0216","LU1979443071.USD","LU2495084118.USD","LU0572944931.SGD","LU1997244956.HKD","LU1997245177.USD","BK1576","LU2242644610.SGD","BK1141","LU0320764599.SGD","LU2125910500.SGD","LU0348767384.USD","LU1770034418.SGD","IE00B543WZ88.USD","LU0456842615.SGD","LU1997245094.SGD","LU0348766576.USD","LU1969619763.USD","159828","LU1251922891.USD","LU0052750758.USD","LU2045819591.USD","CXO","IE00B5MMRT66.SGD","LU0700851271.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660910119","title":"药明康德A、H股双双涨超4%创历史新高 总市值突破5000亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2660910119","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660910119?lang=zh_cn&edition=full","pubTime":"2026-08-17 11:11","pubTimestamp":1786936269,"startTime":"0","endTime":"0","summary":"药明康德A、H股双双涨超4%创历史新高 总市值突破5000亿","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173842946814.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173842946814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B5MMRT66.SGD","LU2125910500.SGD","IE00BPRC5H50.USD","LU1046422090.SGD","LU0700851271.USD","BK1583","IE00B543WZ88.USD","LU0456842615.SGD","LU1979443071.USD","BK0216","LU1997245094.SGD","LU0348766576.USD","LU0052750758.USD","LU0320764599.SGD","LU1997245177.USD","LU0327786744.USD","LU0572944931.SGD","LU2045819591.USD","02359","LU1808992512.USD","LU2495084118.USD","LU2488822045.USD","BK1141","LU1934453819.USD","BK1576","LU2242644610.SGD","603259","LU0348767384.USD","LU0708995583.HKD","LU2328871848.SGD","LU1770034418.SGD","LU0611395673.USD","LU1969619763.USD","LU1303224171.USD","LU1997244956.HKD","LU1251922891.USD","LU1719994722.HKD","LU0469268626.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660109811","title":"【特约大V】邓声兴：港股走势反复，恒指考验100天线","url":"https://stock-news.laohu8.com/highlight/detail?id=2660109811","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660109811?lang=zh_cn&edition=full","pubTime":"2026-08-17 09:47","pubTimestamp":1786931260,"startTime":"0","endTime":"0","summary":"国指跌85点或1.02%，报8340点。科指跌84点或1.77%，报4707点。港股走势反复，恒指考验100天线。集团美国客户收入占比约72%，8月7日美国联邦地区法院批准公司初步禁令动议，美国防部在司法程序期间不得执行1260H清单认定，地缘风险溢价阶段性消退。药明康德正处于业绩超预期、指引上调、订单高增及地缘风险缓解的四重利好交汇点，中线估值重构空间值得跟进。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/NGI2NzYxOTMwNTk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NGI2NzYxOTMwNTk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988335","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","02359","LU0708995583.HKD","LU0327786744.USD","LU2045819591.USD","LU0572944931.SGD","LU0052750758.USD","LU2125910500.SGD","BK1576","LU0348766576.USD","LU1046422090.SGD","603259","BK1141","LU0348767384.USD","LU0469268626.HKD","BK1583","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125476643","title":"摩根大通在药明康德H股空头头寸比例升至3.19%——港交所数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1125476643","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125476643?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:51","pubTimestamp":1786701088,"startTime":"0","endTime":"0","summary":"摩根大通在药明康德H股的空头头寸比例出现显著增长。根据香港交易所最新披露的数据，截至8月11日，该行在药明康德H股上的空头头寸占总股本的比例已从之前的2.66%攀升至3.19%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","LU1969619763.USD","LU0348766576.USD","LU0469268626.HKD","LU1979443071.USD","LU1997244956.HKD","LU0611395673.USD","LU2242644610.SGD","LU1934453819.USD","LU1251922891.USD","LU2495084118.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU0708995583.HKD","603259","LU1046422090.SGD","LU0456842615.SGD","LU1303224171.USD","LU1997245177.USD","LU2045819591.USD","LU0572944931.SGD","BK1583","BK1141","LU1808992512.USD","LU0052750758.USD","LU0327786744.USD","LU0700851271.USD","IE00B543WZ88.USD","LU2125910500.SGD","LU1997245094.SGD","02359","LU1719994722.HKD","BK1576","BK0216","LU0320764599.SGD","LU2328871848.SGD","LU1770034418.SGD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187744","title":"CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187744","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659187744?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:25","pubTimestamp":1786591500,"startTime":"0","endTime":"0","summary":"8月13日，AH医疗板块迅速反弹。CXO强者恒强，药明康德AH股双双涨逾1%，康龙化成AH股齐升逾4%，A股皓元医药涨超7%。场内高CXO含量ETF同步走走强，CXO含量超50%的港股通医疗ETF华宝涨逾1%。全市场规模最大医疗ETF华宝CXO含量超30%，盘中涨超2%冲击五连阳，成交超4.5亿元。紧跟医疗反攻行情，关注两大“利器”：港股通医疗ETF华宝：最新CXO含量达51.88%，其中药明系权重占比超38%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-13/doc-ininctaw3414344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159828","603259","LU2488822045.USD","BK1583","LU1808992512.USD","LU2045819591.USD","LU0052750758.USD","LU1046422090.SGD","LU1997244956.HKD","LU1934453819.USD","LU0708995583.HKD","LU2495084118.USD","LU1770034418.SGD","LU0320764599.SGD","LU1997245177.USD","LU2125910500.SGD","LU0456842615.SGD","IE00B543WZ88.USD","LU2328871848.SGD","BK1576","LU1969619763.USD","IE00BPRC5H50.USD","LU0700851271.USD","512170","BK0216","688131","WX","LU1303224171.USD","LU0611395673.USD","LU1979443071.USD","BK1141","02359","IE00B5MMRT66.SGD","LU0348766576.USD","LU1997245094.SGD","LU2242644610.SGD","LU0348767384.USD","LU1719994722.HKD","LU1251922891.USD","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659182702","title":"美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德(02359)等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659182702","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659182702?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:20","pubTimestamp":1786587659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479310.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSCH","LFSC","PSIL","XBIX","MEDI","SMCO","IDNA","IBRN","APXH","02359","WX","603259","SURI","BMED","161027","CXO","BBC","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659438182","title":"大行评级｜美银：CXO行业受惠生物科技融资强劲，上调药明康德等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659438182","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659438182?lang=zh_cn&edition=full","pubTime":"2026-08-13 10:20","pubTimestamp":1786587637,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02359","LU0348766576.USD","LU0052750758.USD","LU1997245177.USD","LU2125910500.SGD","IE00B543WZ88.USD","BK0216","BK1576","LU1969619763.USD","LU1808992512.USD","BK1141","LU1046422090.SGD","LU2242644610.SGD","LU2488822045.USD","BK1583","LU0700851271.USD","LU1770034418.SGD","LU1303224171.USD","LU0611395673.USD","LU1979443071.USD","LU1719994722.HKD","LU1934453819.USD","LU0708995583.HKD","603259","LU1997244956.HKD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU0348767384.USD","LU1997245094.SGD","LU0320764599.SGD","LU2495084118.USD","LU2328871848.SGD","LU2045819591.USD","LU1251922891.USD","LU0456842615.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657219","title":"药明康德（02359）逆市升2% 大和指禁令代表公司在法律程序中取得初步胜利 重申行业首选","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657219","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658657219?lang=zh_cn&edition=full","pubTime":"2026-08-11 10:00","pubTimestamp":1786413650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德（02359）早盘逆市走高，截至发稿，报202港元，涨2.02%，成交额3.7亿港元。大和研报指，美国哥伦比亚特区联邦地区法院颁发初步禁制令，禁止美国国防部将药明康德列入1260H名单，使公司在诉讼期间免受被错误列入1260H名单所带来的不利后果，将目标市盈率由20倍上调至21.5倍，目标价由215港元升至230港元。该行相信，这项初步禁制令是药明康德从1260H名单除名程序及时的第一步，亦代表公司在法律程序中取得初步胜利，维持“买入”评级。重申行业首选。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987890","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0052750758.USD","LU1303224171.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU1046422090.SGD","LU2495084118.USD","LU0700851271.USD","LU2242644610.SGD","LU1808992512.USD","LU0708995583.HKD","BK1141","603259","LU2488822045.USD","LU0320764599.SGD","LU1719994722.HKD","LU1997245094.SGD","BK0216","LU0348767384.USD","LU2045819591.USD","LU2125910500.SGD","LU1934453819.USD","IE00BPRC5H50.USD","LU1251922891.USD","LU0456842615.SGD","LU1997244956.HKD","LU1969619763.USD","LU0611395673.USD","LU1770034418.SGD","LU2328871848.SGD","BK1583","02359","LU1979443071.USD","IE00B543WZ88.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939798","title":"药明康德：公司将于2026年9月29日召开2026年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939798","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939798?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:34","pubTimestamp":1786365240,"startTime":"0","endTime":"0","summary":"证券日报网讯 8月10日，药明康德发布公告称，公司将于2026年9月29日召开2026年第一次临时股东会。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-10/doc-inimvxci4795165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348767384.USD","LU0456842615.SGD","LU1719994722.HKD","LU1770034418.SGD","LU2495084118.USD","LU0708995583.HKD","LU0348766576.USD","BK0216","LU0320764599.SGD","LU2488822045.USD","BK1576","603259","LU1969619763.USD","LU1251922891.USD","IE00BPRC5H50.USD","02359","LU1046422090.SGD","LU2125910500.SGD","LU2045819591.USD","LU0052750758.USD","LU1997245177.USD","IE00B5MMRT66.SGD","LU1979443071.USD","IE00B543WZ88.USD","LU1997244956.HKD","LU1303224171.USD","LU1997245094.SGD","BK1583","LU0611395673.USD","LU1808992512.USD","BK1141","LU1934453819.USD","LU2328871848.SGD","LU0700851271.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658985600","title":"大行评级｜大摩：药明康德获批出初步禁制令 解除1260H清单不明朗因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2658985600","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658985600?lang=zh_cn&edition=full","pubTime":"2026-08-10 15:28","pubTimestamp":1786346889,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1576","LU0052750758.USD","LU1303224171.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU1046422090.SGD","LU2495084118.USD","LU0700851271.USD","LU2242644610.SGD","LU1808992512.USD","LU0708995583.HKD","BK1141","603259","LU2488822045.USD","LU0320764599.SGD","LU1719994722.HKD","LU1997245094.SGD","BK0216","LU0348767384.USD","LU2045819591.USD","LU2125910500.SGD","LU1934453819.USD","IE00BPRC5H50.USD","LU1251922891.USD","LU0456842615.SGD","LU1997244956.HKD","LU1969619763.USD","LU0611395673.USD","LU1770034418.SGD","LU2328871848.SGD","BK1583","02359","LU1979443071.USD","IE00B543WZ88.USD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658600124","title":"研报掘金丨国盛证券：维持药明康德“买入”评级，大幅上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2658600124","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658600124?lang=zh_cn&edition=full","pubTime":"2026-08-10 14:13","pubTimestamp":1786342438,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1979443071.USD","LU2488822045.USD","BK0052","IE00B543WZ88.USD","LU2495084118.USD","IE00BPRC5H50.USD","LU1719994722.HKD","LU1997244956.HKD","LU1969619763.USD","002670","LU0700851271.USD","LU1303224171.USD","LU1251922891.USD","603259","LU1997245177.USD","LU1934453819.USD","BK0216","LU0611395673.USD","LU0456842615.SGD","LU2328871848.SGD","LU1770034418.SGD","LU1808992512.USD","IE00B5MMRT66.SGD","LU1997245094.SGD","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658043626","title":"时隔5个月，华宝基金医疗ETF（512170）重新站上年线！药明康德A股突破上轮医药牛市高点，创上市8年新高！","url":"https://stock-news.laohu8.com/highlight/detail?id=2658043626","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658043626?lang=zh_cn&edition=full","pubTime":"2026-08-10 11:17","pubTimestamp":1786331820,"startTime":"0","endTime":"0","summary":"8月10日，A股医疗板块继续向上！CXO再爆发，博腾股份、康龙化成续涨超5%，权重龙头药明康德A股盘中飙升逾7%，一举突破上轮医药牛市前高，创历史新高！全市场规模最大医疗ETF华宝继上日大涨4.53%后，盘中再度冲上4%，场内价格创本轮反弹新高，时隔5个月重新站上年线，不到半日成交额近10亿元！数据显示，医疗ETF华宝标的指数覆盖8只CXO龙头股，最新权重合计32.82%，其中药明康德占比13.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimuzxp1261719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997245177.USD","LU1979443071.USD","LU0708995583.HKD","LU0348767384.USD","LU2495084118.USD","IPOS","159938","LU0611395673.USD","BK1583","512170","02359","09939","159828","LU2488822045.USD","159982","LU0320764599.SGD","LU1808992512.USD","BK1515","LU1303224171.USD","603259","LU2328871848.SGD","LU2242644610.SGD","LU1969619763.USD","BK1141","LU0348766576.USD","BK0216","LU1770034418.SGD","IE00B5MMRT66.SGD","LU2045819591.USD","LU1719994722.HKD","BK1574","LU0052750758.USD","LU0700851271.USD","399300","BK1576","LU2125910500.SGD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU1046422090.SGD","LU1251922891.USD","BK1161","LU1934453819.USD","LU0456842615.SGD","LU1997244956.HKD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658601687","title":"AH异动丨药明康德H股创新高，A股涨超7%，美法院批准针对1260H认定的初步禁令","url":"https://stock-news.laohu8.com/highlight/detail?id=2658601687","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658601687?lang=zh_cn&edition=full","pubTime":"2026-08-10 10:37","pubTimestamp":1786329454,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1719994722.HKD","LU1979443071.USD","BK1583","BK0216","IE00BPRC5H50.USD","LU1770034418.SGD","LU1303224171.USD","BK1141","LU1997245177.USD","LU0456842615.SGD","399300","LU1046422090.SGD","LU0348767384.USD","LU1934453819.USD","159982","LU0708995583.HKD","LU1808992512.USD","LU1251922891.USD","LU2242644610.SGD","LU2045819591.USD","LU1997244956.HKD","603259","LU2495084118.USD","LU2488822045.USD","LU0611395673.USD","BK1576","LU0052750758.USD","LU2125910500.SGD","LU0700851271.USD","LU1997245094.SGD","LU2328871848.SGD","LU1969619763.USD","02359","LU0348766576.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658360603","title":"撕掉重资产标签，药明康德（02359）利润为何越跑越快？","url":"https://stock-news.laohu8.com/highlight/detail?id=2658360603","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658360603?lang=zh_cn&edition=full","pubTime":"2026-08-10 08:30","pubTimestamp":1786321826,"startTime":"0","endTime":"0","summary":"然而，当我们深度剖析药明康德自2025年直至2026年上半年交出的多份财报时，会清晰地发现一个极具行业风向标意义的独特现象——公司的利润增速持续且显著地高于同期营收增速，形成了一道不断扩大的“剪刀差”。利润变现能力持续跃升，铸就“现金奶牛”级HALO资产药明康德二季度整体毛利率与经调利润率双双捅破历史天花板。不仅“能赚钱”，更“能收钱”，药明康德将利润转化为自由现金流的能力正在加速进化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2242644610.SGD","LU1934453819.USD","IE00B5MMRT66.SGD","LU0320764599.SGD","LU1997244956.HKD","LU0700851271.USD","LU2125910500.SGD","LU0708995583.HKD","02359","BK1576","LU0456842615.SGD","LU2328871848.SGD","BK0216","LU1808992512.USD","LU1251922891.USD","LU0611395673.USD","LU0348767384.USD","LU1969619763.USD","LU0052750758.USD","LU0348766576.USD","BK1141","LU2045819591.USD","LU1997245177.USD","LU1770034418.SGD","LU2495084118.USD","BK1583","LU1979443071.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","603259","LU1997245094.SGD","LU1719994722.HKD","LU2488822045.USD","LU1303224171.USD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787272881299,"stockEarnings":[{"period":"1week","weight":0.0343},{"period":"1month","weight":0.3278},{"period":"3month","weight":0.6404},{"period":"6month","weight":0.6737},{"period":"1year","weight":0.864},{"period":"ytd","weight":0.8818}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡药明康德新药开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"261368人(较上一季度减少8.34%)","perCapita":"9462股","listingDate":"2018-05-08","address":"江苏省无锡市滨湖区马山五号桥","registeredCapital":"298375万元","survey":" 无锡药明康德新药开发股份有限公司的主营业务是为全球医药及生命科学行业提供一体化、端到端的新药研发和生产服务。公司的主要产品是化学业务、测试业务、生物学业务、其他业务。","listedPrice":21.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,603259,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(603259)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(603259)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}